Silver Book Fact

Anti-VEGF Letter Improvement

Fact image

An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.

Brown D, Nguyen Q, Marcus D, et al. Long-Term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-month results from two phase III trials: RISE and RIDE. Ophthalmol. 2013. http://www.aaojournal.org/article/S0161-6420(13)00212-1/abstract. Accessed May 17, 2016

Reference

Title
Long-Term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-month results from two phase III trials: RISE and RIDE
Publication
Ophthalmol
Publication Date
2013
Authors
Brown D, Nguyen Q, Marcus D, et al
Volume & Issue
Volume 120, Issue 10
Pages
324-30
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • DR Treatment Reduced Risk of Blindness
    Appropriate treatment can reduce the risk of blindness or moderate vision loss from DR by more than 90%.  
  • Mobile Exam for DR
    Use of a mobile examination for DR screening in Finland decreased visual impairment by 86% in the covered area.  
  • A diabetes self-management education program for Medicaid recipients, consisting of a 60 minute initial individual assessment of needs, followed by 12 hours of group education on nutrition and self-management, resulted…  
  • Therapy that keeps blood glucose levels as close to normal as possible in type 1 diabetics, reduces damage to the eyes by 76%. Experts believe that these results can…  
  • A recent study conducted by the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) so clearly demonstrated that lifestyle interventions reduced the risk of developing type 2 diabetes…